{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T12:21:31Z","timestamp":1771676491517,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,27]],"date-time":"2018-03-27T00:00:00Z","timestamp":1522108800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the Japan Labour Health and Welfare Organization"},{"name":"the Ministry of Health, Labor and Welfare, Japan"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-018-4293-x","type":"journal-article","created":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T22:54:09Z","timestamp":1522796049000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Quality of life of survivors of malignant pleural mesothelioma in Japan: a cross sectional study"],"prefix":"10.1186","volume":"18","author":[{"given":"Yasuko","family":"Nagamatsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Oze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Aoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuyuki","family":"Hotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuya","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junko","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takumi","family":"Kishimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4516-0433","authenticated-orcid":false,"given":"Nobukazu","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,27]]},"reference":[{"key":"4293_CR1","volume-title":"Chrysotile asbestos","author":"World Health Organization","year":"2014","unstructured":"World Health Organization. Chrysotile asbestos. 2014. \n                    www.who.int\/ipcs\/assessment\/...\/chrysotile_asbestos_summary.pdf"},{"key":"4293_CR2","volume-title":"Elimination of asbestos-related diseases","author":"World Health Organization","year":"2006","unstructured":"World Health Organization. Elimination of asbestos-related diseases. 2006. \n                    whqlibdoc.who.int\/hq\/2006\/WHO_SDE_OEH_06.03_eng.pdf\n                    \n                  ."},{"key":"4293_CR3","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1111\/j.1445-5994.2010.02223.x","volume":"40","author":"SC Kao","year":"2010","unstructured":"Kao SC, Reid G, Lee K, Vardy J, Clarke S, van Zandwijk N. Malignant mesothelioma. Intern Med J. 2010;40:742\u201350.","journal-title":"Intern Med J"},{"key":"4293_CR4","first-page":"254","volume":"5","author":"N van Zandwijk","year":"2013","unstructured":"van Zandwijk N, Clarke C, Henderson D, Musk AW, Fong K, Nowak A, et al. Guidelines for the diagnosis and treatment of malignant pleural mesothelioma. J Thorac Dis. 2013;5:254\u2013307.","journal-title":"J Thorac Dis"},{"key":"4293_CR5","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s10147-015-0925-1","volume":"21","author":"S Hasegawa","year":"2016","unstructured":"Hasegawa S, Okada M, Tanaka F, Yamanaka T, Soejima T, Kamikonya N, et al. Trimodality strategy for treating malignant pleural mesothelioma: results of a feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation (Japan mesothelioma interest group 0601 trial). Int J Clin Oncol. 2016;21:523\u201330.","journal-title":"Int J Clin Oncol"},{"key":"4293_CR6","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","volume":"21","author":"NJ Vogelzang","year":"2003","unstructured":"Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol. 2003;21:2636\u201344.","journal-title":"J Clin Oncol"},{"key":"4293_CR7","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1183\/16000617.0063-2016","volume":"25","author":"AC Bibby","year":"2016","unstructured":"Bibby AC, Tsim S, Kanellakis N, Ball H, Talbot DC, Blyth KG, et al. Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment. Eur Respir Rev. 2016;25:472\u201386.","journal-title":"Eur Respir Rev"},{"key":"4293_CR8","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1080\/03007995.2016.1226165","volume":"32","author":"S Mercadante","year":"2016","unstructured":"Mercadante S, Degiovanni D, Casuccio A. Symptom burden in mesothelioma patients admitted to home palliative care. Curr Med Res Opin. 2016;32:1985\u20138.","journal-title":"Curr Med Res Opin"},{"issue":"Suppl 2","key":"4293_CR9","first-page":"ii1","volume":"62","author":"British Thoracic Society Standards of Care Committee","year":"2007","unstructured":"British Thoracic Society Standards of Care Committee. BTS statement on malignant mesothelioma in the UK, 2007. Thorax. 2007;62(Suppl 2):ii1\u2013ii19.","journal-title":"Thorax"},{"key":"4293_CR10","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1200\/JCO.2004.09.147","volume":"22","author":"AK Nowak","year":"2004","unstructured":"Nowak AK, Stockler MR, Byrne MJ. Assessing quality of life during chemotherapy for pleural mesothelioma: feasibility, validity, and results of using the European Organization for Research and Treatment of Cancer Core quality of life questionnaire and lung Cancer module. J Clin Oncol. 2004;22:3172\u201380.","journal-title":"J Clin Oncol"},{"key":"4293_CR11","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.athoracsur.2012.05.102","volume":"94","author":"NM Mollberg","year":"2012","unstructured":"Mollberg NM, Vigneswaran Y, Kindler HL, Warnes C, Salgia R, Husain AN, et al. Quality of life after radical pleurectomy decortication for malignant pleural mesothelioma. Ann Thorac Surg. 2012;94:1086\u201392.","journal-title":"Ann Thorac Surg"},{"key":"4293_CR12","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.lungcan.2011.12.009","volume":"77","author":"O Rena","year":"2012","unstructured":"Rena O, Casadio C. Extrapleural pneumonectomy for early stage malignant pleural mesothelioma: a harmful procedure. Lung Cancer. 2012;77:151\u20135.","journal-title":"Lung Cancer"},{"key":"4293_CR13","first-page":"1193","volume":"9","author":"A Granieri","year":"2013","unstructured":"Granieri A, Tamburello S, Tamburello A, Casale S, Cont C, Guglielmucci F, et al. Quality of life and personality traits in patients with malignant pleural mesothelioma and their first-degree caregivers. Neuropsychiatr Dis Treat. 2013;9:1193\u2013202.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"4293_CR14","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3389\/fpsyg.2018.00205","volume":"9","author":"F Guglielmucci","year":"2018","unstructured":"Guglielmucci F, Franzoi IG, Bonafede M, Borgogno FV, Grosso F, Granieri A. \u201cthe less I think about it, the better I feel\u201d: a thematic analysis of the subjective experience of malignant mesothelioma patients and their caregivers. Front Psychol. 2018;9:205.","journal-title":"Front Psychol"},{"key":"4293_CR15","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s00520-012-1569-6","volume":"21","author":"SC Kao","year":"2013","unstructured":"Kao SC, Vardy J, Harvie R, Chatfield M, van Zandwijk N, Clarke S, et al. Health-related quality of life and inflammatory markers in malignant pleural mesothelioma. Support Care Cancer. 2013;21:697\u2013705.","journal-title":"Support Care Cancer"},{"key":"4293_CR16","volume-title":"National asbestos profile of Japan based on the national asbestos profile by the ILO and the WHO","author":"S Furuya","year":"2013","unstructured":"Furuya S, Takahashi K, Movahed M, Jiang Y. National asbestos profile of Japan based on the national asbestos profile by the ILO and the WHO. 2013. \n                    http:\/\/envepi.med.uoeh-u.ac.jp\/NAPJ.pdf"},{"key":"4293_CR17","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.3390\/ijerph14101261","volume":"14","author":"S Furuya","year":"2017","unstructured":"Furuya S, Takahashi K. Experience of Japan in achieving a total ban on asbestos. Int J Environ Res Public Health. 2017;14:1261. \n                    https:\/\/doi.org\/10.3390\/ijerph14101261\n                    \n                  .","journal-title":"Int J Environ Res Public Health"},{"key":"4293_CR18","volume-title":"Labour and Welfare, Japan. Vital statistics in Japan","author":"Ministry of Health","year":"2016","unstructured":"Ministry of Health, Labour and Welfare, Japan. Vital statistics in Japan. 2016. \n                    http:\/\/www.mhlw.go.jp\/toukei\/saikin\/hw\/jinkou\/tokusyu\/chuuhisyu15\/dl\/chuuhisyu.pdf\n                    \n                   (in Japanese)."},{"key":"4293_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ajim.20246","volume":"49","author":"T Murayama","year":"2006","unstructured":"Murayama T, Takahashi K, Natori Y, Kurumatani N. Estimation of future mortality from pleural malignant mesothelioma in Japan based on an age-cohort model. Am J Ind Med. 2006;49:1\u20137.","journal-title":"Am J Ind Med"},{"key":"4293_CR20","first-page":"69","volume":"12","author":"Y Nagamatsu","year":"2012","unstructured":"Nagamatsu Y, Horinouchi S, Natori Y. The stages and difficulties of patients with malignant pleural mesothelioma. J Hum Care Stud. 2012;12:69\u201381.","journal-title":"J Hum Care Stud"},{"key":"4293_CR21","first-page":"1","volume":"13","author":"Y Nagamatsu","year":"2012","unstructured":"Nagamatsu Y, Horinouchi S, Natori Y. Difficulties faced by nurses in careing for patients with malignant pleural mesothelioma. J Hum Care Stud. 2012;13:1\u201313.","journal-title":"J Hum Care Stud."},{"key":"4293_CR22","first-page":"585","volume":"17","author":"S Moore","year":"2008","unstructured":"Moore S, Teehan C, Cornwall A, Ball K, Thomas J. 'Hands of Time': the experience of establishing a support group for people affected by mesothelioma. Eur J Cancer Care (Engl). 2008;17:585\u201392.","journal-title":"Eur J Cancer Care (Engl)"},{"key":"4293_CR23","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365\u201376.","journal-title":"J Natl Cancer Inst"},{"key":"4293_CR24","doi-asserted-by":"publisher","unstructured":"Miyashita M, Wada M, Morita T, Ishida M, Onishi H, Tsuneto S, et al. Development and validation of the comprehensive quality of life outcome (CoQoLo) inventory for patients with advanced cancer. BMJ Support Palliat Care. 2015; \n                    https:\/\/doi.org\/10.1136\/bmjspcare-2014-000725\n                    \n                  .","DOI":"10.1136\/bmjspcare-2014-000725"},{"key":"4293_CR25","volume-title":"EORTC QLQ-C30 Scoring Manual (3rd edition)","author":"PM Fayers","year":"2001","unstructured":"Fayers PM, Aaronson NK, Bjordal K, Groenvold M, Curran D, Bottomley A, on behalf of the EORTC Quality of Life Group. EORTC QLQ-C30 Scoring Manual (3rd edition). 2001. \n                    https:\/\/wiki.nci.nih.gov\/download\/...\/EORTC_QLQ_C30%20_scoring_Manual.pdf"},{"key":"4293_CR26","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1002\/pon.3162","volume":"22","author":"A Arber","year":"2013","unstructured":"Arber A, Spencer L. It\u2019s all bad news\u2019: the first 3 months following a diagnosis of malignant pleural mesothelioma. Psychooncology. 2013;22:1528\u201333.","journal-title":"Psychooncology"},{"key":"4293_CR27","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/bjc.2015.77","volume":"112","author":"DT Arnold","year":"2015","unstructured":"Arnold DT, Hooper CE, Morley A, White P, Lyburn ID, Searle J, et al. The effect of chemotherapy on health-related quality of life in mesothelioma: results from the SWAMP trial. Br J Cancer. 2015;112:1183\u20139.","journal-title":"Br J Cancer"},{"key":"4293_CR28","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1177\/0269216312464093","volume":"27","author":"H Wood","year":"2013","unstructured":"Wood H, Connors S, Dogan S, Peel T. Individual experiences and impacts of a physiotherapist-led, non-pharmacological breathlessness programme for patients with intrathoracic malignancy: a qualitative study. Palliat Med. 2013;27:499\u2013507.","journal-title":"Palliat Med"},{"key":"4293_CR29","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1750-1172-3-34","volume":"3","author":"A Moore","year":"2008","unstructured":"Moore A, Parker RJ, Wiggings J. Malignant mesothelioma. Orphanet J Rare Dis. 2008;3:34.","journal-title":"Orphanet J Rare Dis"},{"key":"4293_CR30","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.hoc.2005.09.003","volume":"19","author":"H Clayson","year":"2005","unstructured":"Clayson H, Seymour J, Noble B. Mesothelioma from the patient's perspective. Hematol Oncol Clin North Am. 2005;19:1175\u201390. viii","journal-title":"Hematol Oncol Clin North Am"},{"key":"4293_CR31","doi-asserted-by":"publisher","first-page":"66","DOI":"10.12968\/ijpn.2008.14.2.28597","volume":"14","author":"N Hughes","year":"2008","unstructured":"Hughes N, Arber A. The lived experience of patients with pleural mesothelioma. Int J Palliat Nurs. 2008;14:66\u201371.","journal-title":"Int J Palliat Nurs"},{"key":"4293_CR32","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.3389\/fpsyg.2014.01419","volume":"5","author":"F Guglielmucci","year":"2014","unstructured":"Guglielmucci F, Franzoi IG, Barbasio CP, Borgogno FV, Granieri A. Helping traumatized people survive: a psychoanalytic intervention in a contaminated site. Front Psychol. 2014;5:1419.","journal-title":"Front Psychol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4293-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-018-4293-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4293-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T20:22:04Z","timestamp":1553631724000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-018-4293-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,27]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["4293"],"URL":"https:\/\/doi.org\/10.1186\/s12885-018-4293-x","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,27]]},"assertion":[{"value":"17 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the institutional review board of Okayama Rosai Hospital (approval no. 2017\u201322). This study was also approved by the institutional review board of each hospital or institution that distributed the questionnaire to their patients according to their policy. The study was conducted based on the ethical principles of avoiding harm, voluntary participation, anonymity, and protection of privacy and personal information. The purpose, procedures, and confidentiality of the study were explained in written format. The participants were informed that nonparticipation would not disadvantage them. Return of the answered questionnaire was considered to constitute the patient\u2019s consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"350"}}